# A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)

> **NCT00092313** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 271 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** MK0966, rofecoxib
- **DRUG:** Comparator: oxycodone and acetaminophen

## Key facts

- **NCT ID:** NCT00092313
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2002-09
- **Final completion:** 2002-09
- **Target enrollment:** 271 (ACTUAL)
- **Last updated:** 2015-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092313, "A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00092313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*